Business Bankruptcies USA
Docket watch · federal bankruptcy courts
Chapter 11

BioXcel Therapeutics, Inc.

Case No. 26-11360 · District of Delaware

The U.S. Bankruptcy Court for the District of Delaware docketed a Chapter 11 petition for BioXcel Therapeutics, Inc. on Aug 27, 2026 (case no. 26-11360).

Request a correction or removal
Debtor
BioXcel Therapeutics, Inc.
Case number
26-11360
Chapter
Chapter 11 reorganization
Court
District of Delaware
State
Delaware
Petition date
Aug 27, 2026
Petition type
Voluntary
Affiliated debtors
2
Public company
SEC CIK 1720893 · BTAI

BioXcel Therapeutics, Inc. — Chapter 11 reorganization, filed Aug 27, 2026.

The filing puts the automatic stay in place and starts the plan process. Unsecured creditors may see an official committee formed by the U.S. Trustee; claims are usually managed by a court-approved claims agent in larger cases.

Joint filing

Affiliated debtors (2)

Related entities that filed in the same court on the same day under consecutive case numbers. Courts normally administer such cases jointly under the lead case.

  • OnkosXcel Employee Holdings, LLC26-11361
  • OnkosXcel Therapeutics, LLC26-11362
Road map

What usually happens next

The filing date is from the docket; later milestones are the typical sequence for this chapter, not tracked events.

Aug 27, 2026
Petition filed
Debtor-in-possession status and the automatic stay begin.
first days
First-day hearing
Motions on cash collateral, DIP financing, wages and critical vendors.
~ 30 days
341 meeting & committee
U.S. Trustee convenes creditors and may appoint an unsecured creditors' committee.
open
Plan or sale
Plan confirmation, section 363 sale, conversion or dismissal.
Court & records

Where the case is pending

Bankruptcy court
District of Delaware
Delaware · court id DEB
⚖️ Docket on CourtListener 🏛️ Court website 🔒 PACER case record
Venue

Court location (state level)

Pin placed at the state level (Delaware), not at the debtor's address. Map © OpenStreetMap, © CARTO.

Docket note

About this filing

BioXcel Therapeutics, Inc. is listed as debtor in case 26-11360 before the U.S. Bankruptcy Court for the District of Delaware (Delaware). The petition was voluntary and filed under Chapter 11 on Aug 27, 2026. 2 affiliated debtors filed alongside it the same day. The company reported the filing to the SEC under Item 1.03 of Form 8-K (ticker BTAI). Authoritative details — schedules, first-day declarations, hearing dates — sit on the court docket linked on this page.

Summary of a public court record, provided as is. Not legal advice and not an official court document.

Nearby on the docket

Other business filings in Delaware